v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
May 02, 2026
May 03, 2025
Operating activities    
Net loss $ (2,101) $ (4,803)
Add (deduct) items not affecting operating cash flows:    
Depreciation and amortization 616 761
Allowance for doubtful accounts (32) 32
Loss on disposal of property and equipment 0 43
Amortization of deferred financing costs 92 91
Share-based compensation expense 91 146
Capitalized PIK Interest due to loan with former related party 265 243
Equity in net income of equity method investment, net of distributions 719 1,285
Changes in assets and liabilities:    
Receivables, net 11,980 9,873
Inventories (4,475) (3,078)
Prepaid expenses and other current assets (3,007) (3,699)
Accounts payable and accrued expenses (10,726) (11,560)
Other assets and liabilities (2,333) (1,151)
Net cash used in operating activities (8,911) (11,817)
Investing activities    
Payments for capital expenditures (216) (1,424)
Net cash used in investing activities (216) (1,424)
Financing activities    
Proceeds from borrowings under the Revolving Credit Facilities 65,300 63,500
Repayment of borrowings under the Revolving Credit Facilities (55,900) (48,150)
Tax withholdings related to restricted stock vesting (1) 0
Proceeds from issuance of common stock, net of certain fees 0 4
Financing fees 0 (135)
Net cash provided by financing activities 9,399 15,219
Increase in cash, cash equivalents, and restricted cash 272 1,978
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (8) 3
Cash, cash equivalents, and restricted cash, beginning of period 557 666
Cash, cash equivalents, and restricted cash, end of period 821 2,647
Less: restricted cash at end of period 59 59
Cash and cash equivalents per balance sheet at end of period 762 2,588
Supplemental Disclosures of Cash Flow Information    
Cash payments for interest 307 622
Cash payments for income taxes, net of refunds 13 11
Supplemental Disclosures of Non-Cash Investing and Financing Activities    
Capital expenditures in accounts payable and accrued liabilities $ 55 $ 1,116